Picture of Fresenius SE & Co. KGaA logo

FRE — Fresenius SE & Co. KGaA News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Brief: FDA Approves Bomyntra & Conexxence, Biosimilars To Xgeva & Prolia

March 25 (Reuters) - FDA:

FDA APPROVES BOMYNTRA & CONEXXENCE, BIOSIMILARS TO XGEVA & PROLIA - WEBSITE

Further company coverage: FREG.DE

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Fresenius SE & Co. KGaA

See all news